CHICAGO – The investigational oral proteasome inhibitor MLN9708 showed hints of promise in multiple myeloma patients who are relapsed or refractory to treatment, investigators in a small phase I study reported here.
JUMP
Easy Toffee
1 day ago
No comments:
Post a Comment